Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
Launched by UNIVERSITY OF VIRGINIA · Dec 13, 2022
Trial Information
Current as of January 17, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called QuitAid, which is designed to help people in rural Appalachia quit smoking. The trial aims to find out if QuitAid, used alone or with other smoking cessation methods, can effectively support smokers in their journey to quit. Participants will receive at least 4 weeks of nicotine patches to help reduce cravings. Some will also get additional support options, like text messages for encouragement, phone sessions with quit coaches, or extended nicotine replacement therapy, to see which combination works best.
To join this study, you need to be a rural smoker aged 18 or older, who has been smoking at least 5 cigarettes a day for the past 6 months. You should be willing to set a quit date within the next month and have a cell phone for communication. The study is open to both men and women, with no restrictions based on race or age. If you participate, you can expect support from your pharmacist and various resources to help you quit smoking effectively while being closely monitored for your progress.
Gender
ALL
Eligibility criteria
- • Study participants will be rural cigarette smokers from Virginia, Tennessee, Kentucky and North Carolina who visit one of the participating study pharmacies. Pharmacies will be located in rural geographic areas of the Central and South Central subregions of Appalachia that include Virginia, Tennessee, Kentucky and North Carolina, as defined by the USDA Rural-Urban Continuum Codes (RUCC) 4-9, Rural-Urban Commuting Area (RUCA) codes 4-10, or Frontier and Remote (FAR) areas level 4. No exclusionary criteria are based on race, gender, or age.
- Inclusion Criteria include:
- • must be 18 years of age and older
- • must be able to read, speak, and understand English
- • must report smoking at least 5 cigarettes per day for the past 6 months (regardless of non-cigarette tobacco product use)
- • must be willing to set a quit date within the next 30 days
- • must own a cell phone
- • must be willing and able to use NRT in the form of patch or lozenge
- • Not be pregnant or planning to be pregnant in the next 6 months.
- Exclusion Criteria include:
- • are pregnant women (self-reported), breastfeeding, planning to become pregnant during the next 6 months
- • have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)
Trial Officials
Melissa Little, PhD, MPH
Principal Investigator
University of Virginia
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials